KOSPI vs KOSPI200 vs KRX300: Which Korean Index Should You Actually Track?

When I first started looking at Korean equities through a foreign investor lens, the index naming caught me off guard. There are at least three Korean stock indices people throw around without explaining them: KOSPI, KOSPI200, and KRX300. They’re related but not interchangeable, and picking the wrong one can mean tracking a completely different slice of the market than you thought.

This post walks through what each index actually represents, why they exist, and which one matters most for foreign investors who want clean Korea exposure. I’ll also cover the ETF options that track each, both in Korea and on US exchanges.

A quick disclaimer up front: I’m not a licensed advisor, and what follows is just my own working framework after spending time with these indices. Anything actionable should be checked against your own research and probably a real advisor too.




So what is KOSPI, actually?

KOSPI stands for the Korea Composite Stock Price Index. It launched on January 4, 1980, with a base value of 100, and it tracks essentially every common stock listed on the main board of the Korea Exchange. That’s roughly 800 companies as of mid-2026, though the exact count moves with listings and delistings.

The key thing to know about KOSPI is that it’s a market-capitalization-weighted index covering the whole main board. Samsung Electronics alone accounts for a huge chunk of it. SK Hynix, LG Energy Solution, Samsung Biologics, Hyundai Motor, and a handful of other giants make up another significant slice. The remaining 700+ companies share the rest.

When you hear news anchors say “the Korean market closed up 1.2 percent today,” they almost always mean KOSPI. It’s the headline number, the equivalent of how Americans use “the Dow” or “the S&P” interchangeably in casual conversation, even though those track different things.

Here’s what trips up foreign investors though: you can’t actually buy KOSPI directly. There’s no single ETF that perfectly tracks all 800 companies on the main board. Most products that claim to track Korea actually track KOSPI200, which is a different beast.

Why KOSPI200 matters more for foreigners

KOSPI200 launched on June 14, 1994, and as the name suggests, it tracks the 200 largest and most liquid companies on the KOSPI main board. The Korea Exchange rebalances the constituents twice a year, in June and December, based on market cap and trading liquidity.

For foreign investors, this is usually the index you actually care about. Two reasons.

First, almost every ETF that gives you “Korea exposure” tracks KOSPI200 or something very close to it. iShares MSCI South Korea ETF (ticker EWY) tracks the MSCI Korea index, which overlaps heavily with KOSPI200 constituents. KODEX 200, TIGER 200, and other Korean-listed ETFs track KOSPI200 directly. If you buy “Korea” through a fund, you’re probably buying KOSPI200 whether you knew it or not.

Second, KOSPI200 is where the futures and options market lives. Korea has one of the most active equity index derivatives markets in the world, and the entire derivatives ecosystem is built around KOSPI200, not the broader KOSPI. Foreign institutional flows show up in KOSPI200 futures positioning before they show up anywhere else. If you’re trying to read what global capital thinks about Korea, KOSPI200 futures open interest is the cleaner signal.

The trade-off is that KOSPI200 is heavily concentrated in mega-caps. Samsung Electronics and SK Hynix alone can drive multi-percent swings. If you want exposure to mid-caps or small-caps in Korea, KOSPI200 won’t give it to you in any meaningful quantity.

KRX300, the newer one most people skip

KRX300 is the one most articles forget to mention. It launched on February 5, 2018, and it’s a combined index that pulls the top 237 stocks from the KOSPI main board and the top 63 stocks from the KOSDAQ market into a single 300-stock benchmark.

Why does this exist? The Korea Exchange wanted a benchmark that captured both markets, large-cap and growth-oriented mid-cap, in one product. Up until 2018, foreign investors who wanted balanced Korea exposure had to buy both a KOSPI200 ETF and a KOSDAQ150 ETF separately. KRX300 was meant to solve that with one product.

In practice, KRX300 has been slower to gain traction than KOSPI200. Most foreign-oriented ETFs still track MSCI Korea or KOSPI200. Korean retail and institutional investors do use KRX300 as a more diversified domestic benchmark, but you’ll rarely see it referenced in English-language coverage.

The one case where KRX300 genuinely matters: if you want exposure to Korean biotech, gaming, and tech mid-caps that live on KOSDAQ but get filtered out of KOSPI200, KRX300 catches them. Companies like Celltrion (which started on KOSDAQ before moving), NCSOFT, Krafton, and several smaller pharma names sit in this overlap zone.

Which one to actually track

Here’s the framework I’ve settled on after staring at this for a while.

If you want a single broad measure of Korea: track KOSPI, but recognize you can’t directly invest in it. Use it for context and headline reading.

If you want investable Korea exposure with deep liquidity: pick a fund that tracks KOSPI200 or MSCI Korea, which are very similar. EWY (iShares MSCI South Korea) is the most common US-listed option. For Korean-listed ETFs, KODEX 200 (069500), TIGER 200 (102110), and KBSTAR 200 (148020) all do the same thing with slightly different expense ratios.

If you want broader diversification including KOSDAQ growth names: track KRX300, or buy KOSPI200 plus KOSDAQ150 separately. Liquidity is thinner for KRX300-tracking ETFs, so the second option is often more practical.

For most foreign investors coming to Korea for the first time, the answer is simple: start with EWY or a KOSPI200 ETF, and only move beyond it if you have a specific thesis on Korean mid-caps or growth names.

How I’d think about ETF picks here

A few practical notes on the funds that actually trade.

EWY is the de facto US-listed Korea ETF. It has roughly 5 to 7 billion dollars in assets depending on the cycle, decent daily liquidity, and an expense ratio of about 59 basis points. It tracks MSCI Korea, which includes a few names like Naver and Kakao that show up in KOSPI200 too, so the overlap is substantial.

FLKR (Franklin FTSE South Korea ETF) is the lower-cost alternative at around 19 basis points but has smaller assets and lower trading volume. For long-term buy-and-hold investors, FLKR’s expense ratio advantage compounds over time. For active traders, EWY’s tighter spreads usually win.

HEWY (iShares Currency Hedged MSCI South Korea) is the dollar-hedged version. Whether to use it depends entirely on your view of the Korean won. The won has been notoriously volatile against the dollar, so for US investors who don’t want FX risk, HEWY removes that exposure at the cost of hedging fees of roughly 20 basis points.

If you can access Korean-listed ETFs through your brokerage (some US brokers offer this, most don’t), KODEX 200 is the largest single Korean equity ETF by assets and the most heavily traded. Expense ratio is around 15 basis points, which is dramatically cheaper than US-listed Korea ETFs. The catch is currency exposure and the operational friction of holding KRW-denominated assets.

A few things to watch

Korea’s index ecosystem isn’t static. There are a few changes worth tracking.

The Korea Value-Up Index launched in late 2024 as a separate benchmark designed around companies that meet capital efficiency and shareholder return criteria. It’s a thematic overlay on KOSPI and KOSDAQ rather than a replacement, but several ETFs now track it. If the Value-Up Program continues to gain regulatory tailwinds, this index could grow in importance relative to KOSPI200.

KOSDAQ150 reform is also on the regulatory radar. Korea has been working on improving the KOSDAQ market’s investability for foreign investors, which could mean methodology changes for the KOSDAQ150 sub-index that feeds into KRX300.

And finally, watch MSCI’s classification of Korea. There’s been a long-running debate about whether Korea should be reclassified from Emerging Market to Developed Market status under MSCI’s framework. If that ever happens, MSCI Korea ETFs (which most foreign Korea exposure runs through) could see substantial flow changes as Korea exits EM benchmarks and enters DM benchmarks. It’s been talked about for over a decade without happening, but it’s still on the radar.

For most foreign investors, the takeaway is simpler than the detail above suggests. KOSPI is the headline. KOSPI200 is what you actually invest in. KRX300 is for cases where you want broader exposure including KOSDAQ. Pick the one that matches your thesis and don’t overthink it.

References

  • Korea Exchange. (2025). KOSPI Index methodology and constituent data. Seoul: KRX.
  • Korea Exchange. (2024). KOSPI200 and KRX300 index methodology. KRX.
  • iShares. (2025). MSCI South Korea ETF (EWY) fact sheet. BlackRock.
  • Franklin Templeton. (2025). FTSE South Korea ETF (FLKR) fact sheet.
  • Financial Services Commission of Korea. (2024). Korea Value-Up Program guidelines. Seoul: FSC.

Disclaimer: This article is for educational purposes only and does not constitute investment advice. The author is not a licensed financial advisor and offers personal analysis only. ETF expense ratios, asset sizes, and constituent details change over time and should be verified directly with the fund providers before any investment decision. Consult a qualified financial advisor before making investment decisions.

Comments

Post a Comment

Popular posts from this blog

Why Are Korean Stocks Cheaper? Understanding the Korea Discount

Image
If you’ve ever pulled up a chart of KOSPI and wondered why it trades at half the multiples of the S&P 500, you’re not the first. Foreign investors have been asking that question for years. Korean academics have written hundreds of papers about it. And in 2024, the Korean government finally decided to do something about it. The phenomenon has a name: the Korea Discount . Korean stocks, on average, trade at lower price-to-book and price-to-earnings ratios than their developed-market peers, even when their underlying businesses look healthy. For global investors, it’s a real and persistent puzzle worth unpacking. I want to walk through what I think is the most useful way to understand it: where it comes from, what changed in 2024, and what to actually watch from here. So what exactly is the Korea Discount? The simplest definition is this: Korean listed companies, as a group, trade at lower valuation multiples than companies of similar size and quality in the United States, Europe,...
Read more

The K-Shipbuilding Super Cycle: LNG, Methanol, and Why Korean Yards Keep Winning

Image
For most of the 2010s, Korean shipbuilders were a story you only paid attention to if you were short. Order books were thin, Chinese yards were eating market share, and the big three Korean names traded like cyclical scrap. Then something shifted, and by the early 2020s the picture had inverted. LNG carrier orders, methanol-fueled containerships, and a structural shortage of yards capable of building complex high-value vessels combined into what people now call the K-shipbuilding super cycle. This post walks through what actually happened, why Korean yards specifically are the ones winning the cycle, and what foreign investors should look at if they want exposure. I’ll cover the four major listed names (HD Korea Shipbuilding, HD Hyundai Heavy, Samsung Heavy, Hanwha Ocean), the fuel transition that’s driving order flow, and the MASGA alliance with the United States that’s quietly shaping the next decade. All financial figures referenced are as of the June 9, 2026 KRX market close, and ...
Read more

Korea Value-Up Program Explained — Buybacks, PBR, 2026 Law

Image
In my last post on the Korea Discount , I ended with a promise: I’d dig into what changed in 2024. This is that post. The short version is that in February 2024, Korea’s Financial Services Commission rolled out something it called the Corporate Value-Up Program . Two years later, with a major Commercial Code amendment now passed and the first wave of low-PBR stocks already rerated, it’s a good moment to look at what actually happened, what’s working, and what isn’t. I’m going to try to be honest about both sides. A lot of the early reporting on Value-Up was either too excited (the cynics call it “K-Value-Up hopium”) or too dismissive (“voluntary disclosure won’t fix structural problems”). The truth, as usual, sits somewhere in between. What the Value-Up Program actually is At its core, the Value-Up Program is a policy framework that asks Korean listed companies to do three things voluntarily: Publish a corporate value-up plan that includes return-on-equity targets and shareholder...
Read more